177 related articles for article (PubMed ID: 3841162)
1. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
Hegele RA; Volpé R
J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
Tallstedt L; Lundell G; Tørring O; Wallin G; Ljunggren JG; Blomgren H; Taube A
N Engl J Med; 1992 Jun; 326(26):1733-8. PubMed ID: 1489388
[TBL] [Abstract][Full Text] [Related]
3. Long-term results following 131I treatment for Graves' disease in Hong Kong Chinese--discriminant factors predicting hypothyroidism.
Kung AW; Pun KK; Lam KS; Choi P; Wang C; Yeung RT
Q J Med; 1990 Sep; 76(281):961-7. PubMed ID: 2236479
[TBL] [Abstract][Full Text] [Related]
4. Relevance of cause of hyperthyroidism in determining its management.
Veneman TF; Weymer M; Tjabbes T; van Haeften TW
Neth J Med; 1989 Dec; 35(5-6):303-8. PubMed ID: 2635287
[TBL] [Abstract][Full Text] [Related]
5. [Follow-up and long-term results of radioiodine therapy in immune hyperthyroidism].
Galvun G
Acta Med Austriaca; 1987; 14(3-4):99-101. PubMed ID: 3425189
[TBL] [Abstract][Full Text] [Related]
6. Iodine-131 treatment of Graves' disease using modified early iodine-131 uptake measurements in therapy dose calculations.
Hayes AA; Akre CM; Gorman CA
J Nucl Med; 1990 Apr; 31(4):519-22. PubMed ID: 2324829
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of thyrotropin binding inhibiting immunoglobulins (TBII) assay in hyperthyroidism.
Duron F; Talbot JN; Féron R; Aubert P; Milhaud G
Biomed Pharmacother; 1987; 41(7):383-8. PubMed ID: 2895672
[TBL] [Abstract][Full Text] [Related]
8. Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease.
Nordyke RA; Gilbert FI
J Nucl Med; 1991 Mar; 32(3):411-6. PubMed ID: 2005449
[TBL] [Abstract][Full Text] [Related]
9. Management of Graves' hyperthyroidism.
Orgiazzi J
Endocrinol Metab Clin North Am; 1987 Jun; 16(2):365-89. PubMed ID: 2446867
[TBL] [Abstract][Full Text] [Related]
10. [131I therapy in hyperthyroidism. Results of treatment from 1960-1974].
Heinze HG; Schenk F
Nuklearmedizin; 1977 Feb; 16(1):1-12. PubMed ID: 846862
[TBL] [Abstract][Full Text] [Related]
11. Incidence of hypothyroidism following small doses of 131I in the treatment of Graves' disease.
McCullagh EP; Jelden GL; Rodriguez-Antunez A
Ohio State Med J; 1976 Sep; 72(9):538-40. PubMed ID: 989600
[No Abstract] [Full Text] [Related]
12. [Long-term results of radioiodine (131I) treatment in 331 patients with Graves' disease (author's transl)].
Saito S; Sakurada T; Yamamoto M; Yoshida K; Kaise K; Kaise N; Yoshinaga K
Nihon Naika Gakkai Zasshi; 1979 Jul; 68(7):724-32. PubMed ID: 113472
[No Abstract] [Full Text] [Related]
13. A prospective study of the effects of radio-iodine therapy on thyroid-stimulating antibody synthesis in Grave's disease [proceedings].
McGregor AM; Petersen MM; Capifferi R; Evered DC; Smith BR; Hall R
J Endocrinol; 1979 May; 81(2):114P-115P. PubMed ID: 222864
[No Abstract] [Full Text] [Related]
14. Iodine-131: optimal therapy for hyperthyroidism in children and adolescents?
Freitas JE; Swanson DP; Gross MD; Sisson JC
J Nucl Med; 1979 Aug; 20(8):847-50. PubMed ID: 583469
[TBL] [Abstract][Full Text] [Related]
15. [Long term effects of the treatment of the Graves' disease by 4 different therapeutics (author's transl)].
Mornex R; Quintana J; Chavrier B
Ann Endocrinol (Paris); 1977; 38(4):273-82. PubMed ID: 578399
[TBL] [Abstract][Full Text] [Related]
16. Transient hypothyroidism after iodine-131 treatment of Graves' disease.
Gómez JM; Virgili N; Soler J; Fernández M; Montaña E
Thyroidology; 1989 Dec; 1(3):149-52. PubMed ID: 2484879
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral content in hypothyroid male patients with hormone replacement: a 3-year study.
Toh SH; Brown PH
J Bone Miner Res; 1990 May; 5(5):463-7. PubMed ID: 2195844
[TBL] [Abstract][Full Text] [Related]
18. Undetected latrogenic hypothyroidism: a late complication of radio-iodine therapy.
Smidt KP; Johnston E
N Z Med J; 1975 Apr; 81(537):325-8. PubMed ID: 1056550
[TBL] [Abstract][Full Text] [Related]
19. A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism.
Marcocci C; Gianchecchi D; Masini I; Golia F; Ceccarelli C; Bracci E; Fenzi GF; Pinchera A
J Endocrinol Invest; 1990 Jun; 13(6):513-20. PubMed ID: 2258580
[TBL] [Abstract][Full Text] [Related]
20. Discriminant factors affecting early outcome of radioiodine treatment for Graves' disease.
Kung AW; Choi P; Lam KS; Pun KK; Wang C; Yeung RT
Clin Radiol; 1990 Jul; 42(1):52-4. PubMed ID: 2390837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
